IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COM NEW
Total 13F shares
4,831,932
Share change
-684,393
Total reported value
$1,359,258
Price per share
$0.28
Number of holders
29
Value change
-$222,386
Number of buys
7
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
3/4/5
10%+ Owner
class O/S missing
13,823,529
$4,700,000 22 Mar 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
1,218,965
$508,187 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
class O/S missing
1,149,268
$479,245 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
852,444
$355,432 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
class O/S missing
703,798
$293,413 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
627,840
$261,746 30 Sep 2025
13F
Rohit Goel
3/4/5
Senior Director of Finance&PAO
class O/S missing
235,000
$79,900 13 May 2021
STATE STREET CORP
13F
Company
class O/S missing
160,207
$66,790 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
113,407
$47,279 30 Sep 2025
13F
John E. Lynch
3/4/5
Director
mixed-class rows
396,901
mixed-class rows
$45,696 31 May 2022
Virtu Financial LLC
13F
Company
class O/S missing
89,546
$37,000 30 Sep 2025
13F
DEARBORN PARTNERS LLC
13F
Company
class O/S missing
84,401
$35,187 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
65,541
$27,324 30 Sep 2025
13F
HRT FINANCIAL LP
13F
Company
class O/S missing
60,258
$25,000 30 Sep 2025
13F
Fisher Asset Management, LLC
13F
Company
class O/S missing
43,400
$18,093 30 Sep 2025
13F
TRUIST FINANCIAL CORP
13F
Company
class O/S missing
36,667
$15,290 30 Sep 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
class O/S missing
34,948
$15,000 30 Sep 2025
13F
TWO SIGMA SECURITIES, LLC
13F
Company
class O/S missing
35,028
$14,603 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
class O/S missing
34,003
$14,176 30 Sep 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
class O/S missing
27,821
$12,000 30 Sep 2025
13F
WOLVERINE TRADING, LLC
13F
Company
class O/S missing
18,479
$7,761 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
class O/S missing
17,707
$7,382 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
13,962
$5,821 30 Sep 2025
13F
THOMPSON DAVIS & CO., INC.
13F
Company
class O/S missing
10,000
$4,169 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
9,793
$4,083 30 Sep 2025
13F
Baader Bank Aktiengesellschaft
13F
Company
class O/S missing
13,961
$3,598 30 Sep 2025
13F
GROUP ONE TRADING LLC
13F
Company
class O/S missing
7,187
$2,996 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
3,958
$1,647 30 Sep 2025
13F
UBS Group AG
13F
Company
class O/S missing
3,045
$1,270 30 Sep 2025
13F
Geneos Wealth Management Inc.
13F
Company
class O/S missing
3,000
$1,260 30 Sep 2025
13F
CIBC Private Wealth Group LLC
13F
Company
class O/S missing
655
$273 30 Sep 2025
13F
Caitlin John, LLC
13F
Company
class O/S missing
200
$83 30 Sep 2025
13F
Farther Finance Advisors, LLC
13F
Company
class O/S missing
100
$42 30 Sep 2025
13F
Hurley Capital, LLC
13F
Company
class O/S missing
100
$42 30 Sep 2025
13F
DHJJ Financial Advisors, Ltd.
13F
Company
class O/S missing
80
$34 30 Sep 2025
13F
EVERMAY WEALTH MANAGEMENT LLC
13F
Company
class O/S missing
30
$13 30 Sep 2025
13F
FMR LLC
13F
Company
class O/S missing
5
$2 30 Sep 2025
13F
Terry L. Lierman
3/4/5
Director
class O/S missing
500,000
17 Oct 2025

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2025

As of 31 Dec 2025, IGC Pharma, Inc. - COM NEW (IGC) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,831,932 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., CITADEL ADVISORS LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, DEARBORN PARTNERS LLC, and LAWOOD & CO. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
34
Q4 2025 holders
29
Holder diff
-5
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .